Herpes zoster-Pediatric Oncall

ISSN 0973 - 0958

Drugs

Clinical Tools

Clinical Vignettes

Diseases & Conditions

Drugs Interaction Calculator

Podcasts

Patient Management Online

Diagnostic Dilemma

Question of the Day

Medical Quiz

Interactives

Ask Queries

SPECIALIST ANSWERS

Rakesh Kumar, Puja Bhagat Department of Pediatrics, Katihar Medical College, Katihar, Bihar, India ...

Video Podcast

Videos in Medicines

Medical Training Videos

Clnical Video Resource

Videos on Asthma

Audio Cast

Lecture on Pediatrics

Medical Training Audios

Clnical Audio Resources

Audios on Asthma

Mobile (wap)

Staying connected to Pediatric Oncall is now easier with Pediatric Oncall Mobile . You can now download selected content from the latest issue of Pediatric Oncall.

Research Grant

FIND DIAGNOSIS

VACCINE REMINDER

Get the Vaccine Schedule for your child."

	Specialist Answers
Question
How aciclovir help a patient with varicella? Does it prevent herpes zoster? 2.is ivermectin- albendazole combination rational? 3.in rti cefixime or cefpodoxime ,which molecule is superior? 4.should i give opv\ipv to all patients?
Answer
1. Read the article on VARICELLA ZOSTER VIRUS on www.pediatriconcall.com or from the link given below: http://www.pediatriconcall.com/fordoctor/DiseasesandCondition/infectious_diseases/varicellazoster.asp 2. Ivermectin is contraindicated in children <5 years of age. It is used in treatment of Onchocerciasis, Filariasis, Strongyloidosis, Norwegian scabies. Albendazole is an anthelmintic. For more details read the DRUG INDEX on www.pediatriconcall.com or from the link given below: http://www.pediatriconcall.com/fordoctor/DrugsandMedical/alphabeticaldruglinks.asp 3. Cefpodoxime proxetil is an orally administered extended spectrum, semi-synthetic antibiotic of the cephalosporin class. Cefixime has predominantly gram negative coverage (cefixime has poor efficacy against staphylococcus, and streptococci) but has also been found useful in respiratory infection. However Cefpodoxime proxetil is a well tolerated and superior alternative to the earlier oral third generation cefixime for LRTIs in children. The cost is the major deterrant. 4. OPV has not shown herd effectiveness it has failed to protect non-immunizedchildren in UP and Bihar, or for that matterany where in the country (and has even failed to protect some who have received more than adequate number of OPV doses). This means that one needs to achieve near 100% coverage during routine immunization and SIAs with OPV.This is nearly impossible. In addition one needs to give a staggering 10-15 doses of OPV in UP and Bihar for individual protection with OPV, that too as early in life as possible, preferably before the ageof 6-12 months to interrupt wild poliovirus transmission. IPV is known to lead to 95-98%protection of the individual given 3 doses. Many western countries have eradicated polio by using IPV alone or along with OPV. IPV has no risk of VAPP. Thus a schedule of IPV and OPV is suggested as follows: Birth: OPV 6 Weeks: IPV 10 Weeks: IPV 14 Weeks: IPV 15 months: IPV 5 years: IPV Back to All Questions

Diseases & Conditions

Pediatric Oncall Journal

Pediatric Conferences

Ped Tools

Adverse Drug Reactions

Head circuferences Calculator

Mid parental height Calculator

Body surface area Calculator

BMR Calculator

Temperature Calculator

Anion gap Calculator

Today's Poll

Should all patients with viral respiratory infection be treated with oseltamivir in current epidemic of H1N1 influenza_?

Yes, it may be H1N1

No, only if test is positive for influenza

Only in sick patients admitted in ICU

Vote

Results

Pediatric oncall book store

Partner Sites

Infection in Children

Pedcall

Medical ADRIS

Vaccine Reminder

Pediatric Oncall Journal

Educational Section

Nutrition

Skin Problems

Swine Flu Center

Health Solutions from our sponsors

DHA

Baby Massage

Disclaimer:

The information given by www.pediatriconcall.com is provided by medical and paramedical & Health providers voluntarily for display & is meant only for informational purpose. The site does not guarantee the accuracy or authenticity of the information. Use of any information is solely at the user's own risk. The appearance of advertisement or product information in the various section in the website does not constitute an endorsement or approval by Pediatric Oncall of the quality or value of the said product or of claims made by its manufacturer.

Sitemap For Doctor

Sitemap For Parent

Sitemap For Kids